Summary
This Form 8-K filing from WellPoint, Inc. (now Elevance Health, Inc.) on September 22, 2006, primarily details a material definitive agreement related to a significant secondary offering of company stock. Specifically, it announces the completion of the sale of 7,000,000 shares of common stock by The New York Public Asset Fund, acting as the selling stockholder, to underwriters including Goldman, Sachs & Co. and J.P. Morgan Securities Inc. It is crucial for investors to note that WellPoint, Inc. itself did not receive any proceeds from this transaction. The shares were sold by the existing stockholder at a price of $74.9522 per share, with a public offering price of $77.50 per share. This event signifies a substantial transfer of ownership from a major shareholder rather than a capital raise for the company.
Key Highlights
- 1Completion of a secondary offering of 7,000,000 shares of WellPoint, Inc. common stock.
- 2The offering was conducted by The New York Public Asset Fund (Selling Stockholder) through underwriters Goldman, Sachs & Co. and J.P. Morgan Securities Inc.
- 3The sale price to underwriters was $74.9522 per share.
- 4The public offering price for the shares was $77.50 per share.
- 5WellPoint, Inc. did not receive any proceeds from this stock sale, indicating it was not a primary offering to raise capital for the company.
- 6The Underwriting Agreement, dated September 18, 2006, is filed as an exhibit.
- 7The filing was made on September 22, 2006, reporting an event date of September 18, 2006.